Adverse event reporting in patients treated with thyroid hormone extract

Endocrine Practice

Volumn 23, Issue 5, 2017, Pages 566-575

  Shrestha, Rupendra T ^a   Malabanan, Alan ^b   Haugen, Bryan R ^c   Levy, Elliott G ^d   Hennessey, James V ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE; TISSUE EXTRACT;

ARTICLE; CONSTIPATION; DRY SKIN; EUTHYROIDISM; GOITER; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MENSTRUAL IRREGULARITY; NERVOUSNESS; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION TEST; THYROTOXICOSIS; TREATMENT RESPONSE; WEIGHT REDUCTION; ADULT; ADVERSE EFFECTS; BLOOD; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HORMONE SUBSTITUTION; PATHOPHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; THYROID GLAND;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; SURVEYS AND QUESTIONNAIRES; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE; TISSUE EXTRACTS; TRIIODOTHYRONINE;

EID: 85022329284     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP161584.OR     Document Type: Article

References (25)

1. Slater S. The discovery of thyroid replacement therapy. Part 3: a complete transformation. J R Soc Med. 2011;104: 100-106.
2. Slater S. The discovery of thyroid replacement therapy. Part 1: in the beginning. J R Soc Med. 2011;104:15-18.
3. Surks MI, Schadlow AR, Oppenheimer JH. A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement. J Clin Invest. 1972;51:3104-3113.
4. Jackson IM, Cobb WE. Why does anyone still use desiccated thyroid USP? Am J Med. 1978;64:284-288.
5. Smith SR. Desiccated thyroid preparations. Obsolete therapy. Arch Intern Med. 1984;144:926-927.
6. Aitken M, Kleinrock M, Lyle J, Nass D, Caskey L. Medicines use and spending shift. QuintilesIMS 2014. Available at: http://www.imshealth.com/en/thought-leadership/quintilesims-institute/reports/medicines-use-in-the-us-2014. Accessed March 15, 2017.
7. Hennessey JV. Historical and current perspective in the use of thyroid extracts for the treatment of hypothyroidism. Endocr Pract. 2015;21:1161-1170.
8. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:988-1028.
9. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24:1670-1751.
10. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1:55-71.
11. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081-1125.
12. Armour Thyroid (thyroid): drug summary. PDR. Available at: http://www.pdr.net/drug-summary/armour-thyroid?druglabelid=2466. Accessed March 15, 2017.
13. Nature-Throid (thyroid): full prescribing information. Available at: http://www.pdr.net/full-prescribing-information/Nature-Throid-thyroid-496. Accessed March 15, 2017.
14. Gaby AR. Sub-laboratory hypothyroidism and the empirical use of armour thyroid. Altern Med Rev. 2004;9:157-179.
15. Siegmund W, Spieker K, Weike AI, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf). 2004;60:750-757.
16. Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142: 412-424.
17. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-Analysis of randomized controlled trials. J Clin Endocrinol Metab. 2006;91:2592-2599.
18. Ma C, Xie J, Huang X, et al. Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun. 2009;30:586-593.
19. Lichten EM. Synthetic thyroxine vs dessicated thyroid. JAMA. 2004;291:1445; author reply 1445.
20. Jellinger PS. Acquired hypothyroidism after switching from thyroid USP to levothyroxine. Clin Cornerstone. 2005;7(suppl 2):S22-S24.
21. Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98:1982-1990.
22. Hennessey JV. Levothyroxine a new drug? Since when? How could that be? Thyroid. 2003;13:279-282.
23. U.S. Department of Health and Human Services, U.S. Food and Drug Administration. Orange Book: approved drug products with therapeutic equivalence evaluations. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/. Accessed March 22, 2017.
24. Hennessey JV, Malabanan AO, Haugen BR, Levy EG. Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr Pract. 2010;16:357-370.
25. Reid RO, Rabideau B, Sood N. Low-value health care services in a commercially insured population. JAMA Intern Med. 2016;176:1567-1571.